BOSTON and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for ...

Phase 2 data expected in 2H 2026 - - KPL-387 Phase 1 single ascending dose data support profile for monthly dosing - LONDON, ...

June 5, 2025 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, today announced that all participants have ...

LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 ...

CHENNAI: Shares of Dr Reddy’s Laboratories surged over 3% in early trade on Thursday after the Indian drug maker announced a ...

Shares of Liminatus Pharma rose in post-market trading after the pre-clinical stage biopharmaceutical company said it regained compliance with Nasdaq listing requirements. The stock rallied 77% to $22 ...

PHAXIAM Therapeutics (Euronext: PHXM FR001400K4B1), a biopharmaceutical company ("the Company" or "PHAXIAM") developing innovative treatments for severe and resistant bacterial ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” first quarter 2025 investor letter.

The investment bank says funding was down 57% last month, to $2.7 billion, and argues the new administration’s FDA ...

BofA Securities analysts on Wednesday lifted ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s price target to $23 from $18, while ...

Biodexa Pharmaceuticals ( ($BDRX) ) just unveiled an announcement. On June 4, 2025, Biodexa Pharmaceuticals announced the recruitment of the first ...

The Gross Law Firm issues the following notice to shareholders of Zenas BioPharma, Inc. . Shareholders who purchased shares of ...